Title of article :
Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect
Author/Authors :
M. D. Grynpas، نويسنده , , E. Hamilton، نويسنده , , R. Cheung، نويسنده , , Y. Tsouderos، نويسنده , , P. Deloffre، نويسنده , , M. Hott، نويسنده , , P. J. Marie، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1996
Pages :
7
From page :
253
To page :
259
Abstract :
Low doses of strontium and fluoride were shown to increase bone formation and trabecular bone density in rodents. To assess whether strontium or fluoride affect the quality of the mineral at doses known to increase bone density, we have determined the effects of low doses of strontium and fluoride on bone formation and bone mineral characteristics in rats. Adult rats were given strontium alone (0.20%), fluoride alone (1 mg/kg per day), or the combined treatment for 8 weeks. Strontium levels in serum and femur were similar in groups treated with strontium alone or in combination, being about 5% of calcium levels. Biochemical and neutron activation analyses in femur showed that calcium and magnesium contents did not differ in the four groups of rats, suggesting that strontium was incorporated in the apatite lattice of the bone mineral in the strontium-treated rats. The mineralized bone volume was significantly increased by 17 % in the strontium-treated group, by 20% in the fluoride-treated group, and by 19% in rats given with the combined treatment. This was associated with increased osteoid surface, osteoblast surface, and double tetracycline labeled surfaces in the strontium-treated and fluoride-treated groups, showing that the number of bone forming sites was increased. However, the mineral apposition rate, the osteoid thickness, and the mineralization lag time were similar in controls and treated groups, reflecting the lack of deleterious effects of low doses of strontium and fluoride on bone mineralization. The density fractionation analysis measured in the femur also showed that neither strontium, nor fluoride at the low doses used, significantly altered the mineralization profile. The results indicate that treatment with low doses of strontium or fluoride increase the number of bone forming sites and vertebral bone volume in rats, but does not have detectable adverse effects on the mineral profile, bone mineral chemistry or bone matrix mineralization.
Keywords :
Boneformation , Density fractionation. , strontium , bone mineralization , Fluoride
Journal title :
Bone
Serial Year :
1996
Journal title :
Bone
Record number :
490166
Link To Document :
بازگشت